Ivermectin the Promising Drug to Stave off the COVID-19 Crisis: A Review

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

The Coronavirus disease 2019 (COVID-19) outbreak, forcing us to face unprecedented moments in the world. The huge devastating impact of the world due to the covid-19 attack causes the brink of no return. However, there is no proven and specific treatment for Covid-19. Very few medications have received Emergency Use of Authorization. A recent in vitro study was the first time to find out and to assess the antiviral effect of Ivermectin on COVID-19. The study showed that Ivermectin was active against COVID-19-infected cells, was able to kill effectively almost all viral particles within 48 h. In these moments of crisis, FDA-approved ivermectin is a ray of hope. [Bangladesh Journal of Infectious Diseases, December 2020;7(2):95-98].

Author supplied keywords

Cite

CITATION STYLE

APA

Jahan, Z., & Hassan, M. (2020). Ivermectin the Promising Drug to Stave off the COVID-19 Crisis: A Review. Bangladesh Journal of Infectious Diseases, 7(2), 95–98. https://doi.org/10.3329/bjid.v7i2.51520

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free